“showed a trend”

Being of male gender showed a trend of association with better improvement in scores in the EI (p = 0.08), RAE (p = 0.07), FAH (p = 0.06) domains and TS (p = 0.09) (Table 3s).

None of the memory groups showed significant changes in PTSD symptom trajectories over time compared to the other memory groups (non-significant interaction effects with time), although individuals with delusional memories showed a trend toward worsening of PTSD symptoms from 3 to 12 months compared to those with amnesia ( p = 0.08).

All pathway‐GRSs were associated with CSF Aβ 1‐42 (all FDR adjusted p < 0.05), except for the migration pathway that showed a trend‐level association only (FDR adjusted p = 0.08).

Adults showed a trend toward higher baseline PGA scores compared with children (median PGA 5 (range 3–9) vs. 3 (range 2–9), p = 0.08). 4.3.1.

In our study, impaired preinterventional renal function showed a trend towards higher risk of heart failure rehospitalization ( p = 0.08).

In addition, the cCR rate in the SCRT group was 25% (95% CI: 0.18–0.33, p < 0.001), compared to only 15% (95% CI: 0.07–0.24, p < 0.001) in the LCRT group; although the difference did not reach conventional statistical significance, it showed a trend ( p = 0.08) (Fig. 4 c).

Patients with higher lEV concentrations showed a trend towards longer overall survival (36.1 vs. 16.5 months, p=0.08).

For bisphenols, higher prenatal BPS concentrations showed a trend for increased odds of asthma at 12 months (AOR 2.15, 95% CI = 0.88–5.23, p = 0.08), but reduced odds of eczema (AOR = 0.72, 95% CI = 0.56–0.93, p = 0.01) and rash (AOR = 0.81, 95% CI = 0.67–0.98, p = 0.03) at 36 months.

In terms of safety, ADCs showed a trend toward fewer grade ≥3 Aes (OR = 0.68, p = 0.08), supporting their improved tolerability compared with conventional chemotherapy, and Diéras et al.

Participants receiving PT‐Cy showed a trend towards lower rates of positive CMV specific CD8 + responses (OR 0.44 [95% CI 0.18–1.13], p = 0.08).

In multivariable Cox analysis, a higher radiomics score showed a trend toward shorter RFS [hazard ratios (HRs) 1.46 per SD increase, P=0.08].

Although the detection rates of PCa with GG ≥ 2 for both methods were not statistically different, primary TB showed a trend of being superior compared to systemic PBx ( p = 0.08) [ 25 ].

Three additional proteins, IL-10, IL-1 RA, and MDC, showed a trend for statistical significance ( p < 0.08).

Regarding pathogen type, gram-negative infections showed a trend towards lower mortality (OR 0.53, 95% CI 0.27-1.04, p=0.08), though not statistically significant.

Interestingly, the hyperfractionated regimen of 30 Gy in 10 fractions showed a trend toward being more effective for symptom palliation when compared to the hypofractionated regimen of 20 Gy in 5 ( P = .08; Table E2 , Fig.

Bone Mineral Density Although not statistically significant, hens in the DO-L and DO-H groups showed a trend toward increased BMC and BMD in the tibia compared to the control group ( p = 0.08; Table 4 ).

Interestingly, the number of previous lines of treatment positively correlated with HR cytogenetic ( Figure 4 D; P < .001) and EMD ( Figure 4 E; P < .01) and showed a trend toward increased numbers of CAR+ T EM cells detected in HBI0101 FP ( Figure 4 F; P = .08).

Attaining the quasi-optimal/suboptimal joint PK/PD target of CI piperacillin–tazobactam showed a trend toward a higher risk of microbiological failure (33.3% vs. 0.0%; p = 0.08) (4) Conclusions: Real-time TDM-guided optimal joint PK/PD target attainment of CI piperacillin–tazobactam monotherapy may represent a valuable and effective carbapenem-sparing strategy when dealing with non-severe ESBL-producing Enterobacterales secondary BSIs.

The number of cases completed correlated positively with accuracy improvement ( r = 0.31, p < 0.001), and users who posted ≥ 3 discussion comments showed a trend toward higher improvement (25.1% vs. 23.4%, p = 0.08).

Pooled data from these 6 trials showed a trend to low cardiac death vs. the comparator p = 0.08 in favor ( Figure 1 ) but a significant increase of non-cardiac death in the DES vs. comparator arm (5.5% vs. 3.8%, respectively, p = 0.000018) in favor to comparator Figure 2 .

During the nighttime period, the PCOS group showed a trend toward higher values in mean ( p = 0.080), systolic ( p = 0.088), and diastolic ( p = 0.062) blood pressures, as well as heart rate ( p = 0.055), while pulse pressure did not differ between groups ( p = 0.458).

In models incorporating time‐updated diameter, ATAA size remained associated with all‐cause mortality (HR, 1.43 [95% CI, 1.15–1.77]; P = 0.001) and showed a trend toward association with aortic‐specific mortality (HR, 1.46 [95% CI, 0.96–2.21]; P = 0.08) (Table 3 ).

In an analysis of covariance, BMI and age were not associated with impaired compensation after nephrectomy (absolute and relative ΔeGFR for BMI: P = 0.44 and P = 0.68; and for age: P = 0.78 and P = 0.56); individuals with VO showed a trend toward greater ΔeGFR ( P = 0.08), whereas the association in relative ΔeGFR was not statistically robust ( P = 0.14).

Although third molars showed a trend towards increased risk compared to first molars, this association did not reach statistical significance ( p = 0.08).

Similarly, lack of an MDT steroid plan was significantly linked to Grade 3 complications ( p = 0.01) and showed a trend for Grade 2 ( p = 0.08) but was not associated with Grade 1 toxicity ( p = 0.56).